Hyperbaric Oxygen supports the body’s regenerative capacity

Hyperbaric oxygen therapy (HBOT) provides crucial support for helping to combat accelerating aging along with chronic degenerative condition. This simple and safe procedure provides a surplus of oxygen and cellular energy to help stimulate and enhance the body's reparative and regenerative capacities. "HBOT affects physiological processes at the genetic level by altering gene expression, delaying cell senescence, and assisting in telomere length enhancement. The positive results in a variety of indications, ranging from tissue regeneration to better cognitive function, indicate that it has enormous potential in regenerative and anti-aging therapy." and  here is a quick summary of the results from HBOT:

• HBOT showed a marked improvement in cognitive functions and neuronal health which usually declines with aging
• HBOT affects the epigenetic regulation of many critical genes results in physiological consequences in the form of anti-inflammatory effect, anti-apoptotic and regenerative functions
• The extra oxygen supply is utilized in the process of healing, tissue repair, rebuilding and regeneration.
• The effect is especially beneficial for older individuals as the overall oxygen carrying capacity and regenerative capacity diminishes with age and HBOT helps to compensate for this apparent lack of oxygen in vital processes of healing and regeneration

  ALZHEIMERS

Alzheimer’s disease — researchers find hyperbaric oxygen reduces amyloid plaques and causes large gains in blood flow to the brain

This exciting new study shows that Hyperbaric Oxygen therapy (HBOT) may REVERSE dementia development by preventing the deposit of new amyloid plaques on the brain cells and even leading to the removal of existing ones! The 2 most common types of dementia are vascular dementia and Alzheimer’s disease (AD). It is now believed that hyperbaric oxygen therapy can effectively help to halt both of these devastating conditions, while also being able to help reverse the cognitive decline seen in the aging process. The production of amyloid plaques are a hallmark of AD, consisting of hard, insoluble accumulations of beta amyloid proteins that clump together between the nerve cells and block their communication. Compounding this, is a reduction in oxygen (hypoxia) and reduction in blood flow to these regions inside the brain. Since the pathophysiology includes both the build up of amyloid plaques and a reduction in cerebral blood flow (CBF), the researchers designed this study to deploy a typical course of HBOT and then observe any changes in both amyloid plaque and CBF, while also documenting any clinical improvements. They did this by presenting a 2-fold study, the first being an animal study which was then followed up with a small human study. Both showed extremely promising results and confirmed previous studies for HBOT’s potential role in treating dementia and memory loss. Initial Animal Study: Mice were exposed to 20 HBOT sessions (2.0 ATA, 60 min) causing a significant:

Move over Prozac; Hyperbaric oxygen demonstrates its anti-depressant effects

If you are suffering from depression and have had a past history of head injury or concussion, then pay close attention to a new study published in the Journal of World Neurosurgery, 2017. It is very well known that 50% of those people that are afflicted with a traumatic brain injury (TBI) will also suffer from major depression and be put on antidepressants like Prozac. However, this and many other reasons for depression, are clearly related to inflammation inside the brain (neuroinflammation). With knowledge of this information, along with the understanding of the anti-inflammatory properties of hyperbaric oxygen therapy (HBOT) in the brain, researchers carried out a study to help us evaluate and see if HBOT could provide relief for TBI victims suffering from depression. The results demonstrated that HBOT was able to significantly diminish TBI-induced depression-like behavior, through its anti-inflammatory effects in the brain.

Hyperbaric oxygen helps with chronic fatigue sufferers

Chronic fatigue syndrome (CFS) can be a debilitating condition that effects all ares of the individual's quality of life. Since oxygen is a key driver to the body’s energy stores (ATP), it would make sense that this therapy would be of benefit. This study evaluated 16 patients diagnosed with CFS following 3 weeks of hyperbaric treatments. The results documented improvements in all areas measured and noted that their were no complications and the treatments were well tolerated by all participants. Thus, a short 3 week duration of hyperbaric oxygen therapy could result in significant benefits for this patient population, in terms of quality of life

Low pressure hyperbaric therapy shown effective in helping metabolic syndrome and reducing cardiac risks

A new study in the Journal of atherosclerosis and thrombosis published this year shows that low pressure hyperbaric oxygen therapy can be a very effective tool for helping those suffering from metabolic syndrome. Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes. This study looked at only 1.25 ATA (low pressure hyperbarics) and found that this dosage was effective enough to produce a lowering of blood sugars, blood pressure, total cholesterol, and insulin.